Biomea Fusion advances diabetes drug trials in 2026

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. SPY
4. RH
5. CPRT
6. ACVA
7. SEDG
8. QQQ
9. TENB
10. SPCX

Go back to Biomea Fusion advances diabetes drug trials in 2026
(NASDAQ: BMEA) Delayed: 1.76 +0.06 (3.53%)
Previous Close $1.70    52 Week High $ 
Open $1.75    52 Week Low $ 
Day High $1.78    P/E N/A 
Day Low $1.70    EPS $ 
Volume 1,199,354